416 related articles for article (PubMed ID: 35113247)
1. Molecular mechanisms associated with chemoresistance in esophageal cancer.
Lohan-Codeço M; Barambo-Wagner ML; Nasciutti LE; Ribeiro Pinto LF; Meireles Da Costa N; Palumbo A
Cell Mol Life Sci; 2022 Feb; 79(2):116. PubMed ID: 35113247
[TBL] [Abstract][Full Text] [Related]
2. A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.
Honing J; Smit JK; Muijs CT; Burgerhof JGM; de Groot JW; Paardekooper G; Muller K; Woutersen D; Legdeur MJC; Fiets WE; Slot A; Beukema JC; Plukker JTM; Hospers GAP
Ann Oncol; 2014 Mar; 25(3):638-643. PubMed ID: 24492674
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
[TBL] [Abstract][Full Text] [Related]
4. Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Fan J; Gao W; Wu Y; Zhao Q; Chen B; Ding Y; Wen S; Nan X; Wang B
Stem Cells Dev; 2020 Jun; 29(12):774-785. PubMed ID: 32178572
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
Messager M; Mirabel X; Tresch E; Paumier A; Vendrely V; Dahan L; Glehen O; Vasseur F; Lacornerie T; Piessen G; El Hajbi F; Robb WB; Clisant S; Kramar A; Mariette C; Adenis A
BMC Cancer; 2016 May; 16():318. PubMed ID: 27194176
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
11. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.
Cheng Y; Li K; Diao D; Zhu K; Shi L; Zhang H; Yuan D; Guo Q; Wu X; Liu D; Dang C
Lab Invest; 2013 Dec; 93(12):1276-87. PubMed ID: 24145239
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and therapeutic strategy in platinum resistance lung cancer.
Lv P; Man S; Xie L; Ma L; Gao W
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188577. PubMed ID: 34098035
[TBL] [Abstract][Full Text] [Related]
13. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy.
Adelstein DJ; Rice TW; Rybicki LA; Larto MA; Ciezki J; Saxton J; DeCamp M; Vargo JJ; Dumot JA; Zuccaro G
J Clin Oncol; 2000 May; 18(10):2032-9. PubMed ID: 10811667
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of autophagy regulating chemoresistance in esophageal cancer cells.
Fang F; Li Y; Chang L
Exp Mol Pathol; 2020 Dec; 117():104564. PubMed ID: 33137292
[TBL] [Abstract][Full Text] [Related]
15. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.
Yamasaki M; Makino T; Masuzawa T; Kurokawa Y; Miyata H; Takiguchi S; Nakajima K; Fujiwara Y; Matsuura N; Mori M; Doki Y
Br J Cancer; 2011 Feb; 104(4):707-13. PubMed ID: 21206495
[TBL] [Abstract][Full Text] [Related]
16. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial.
Ai D; Ye J; Wei S; Li Y; Luo H; Cao J; Zhu Z; Zhao W; Lin Q; Yang H; Zheng X; Zhou J; Huang G; Li L; Li J; Zhang Z; Zhou G; Gu D; Du M; Mo M; Jia H; Zhang Z; Zhao K
JAMA Netw Open; 2022 Feb; 5(2):e220120. PubMed ID: 35188552
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
Lan T; Xue X; Dunmall LC; Miao J; Wang Y
Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
